Abstract
The unprecedented progress in aging research has revealed that rapamycin, a clinically approved drug, is actually an anti-aging agent, which potentially could be employed to delay age-related diseases, thus extending healthy life span. The possibility of preventing diseases by staying young is remarkable in itself. At the same time this advance could save Medicare as we know it. Here I discuss how anti-aging interventions could solve otherwise intractable political problems without tax increases or curtailment of health care benefits.
Highlights
The unprecedented progress in aging research has revealed that rapamycin, a clinically approved drug, is an anti‐aging agent, which potentially could be employed to delay age‐related diseases, extending healthy life span
Most importantly, precisely because medicine is becoming so effective in saving lives, this increases a number of elderly patients with chronic and multiple diseases (Figure 1 from A to B), which necessitates multiple treatments all of which cost money
No one dies from aging itself, all humans die from age-related diseases such as cancer, atherosclerosis, hypertension, diabetes, osteoporosis or from their complications
Summary
The unprecedented progress in aging research has revealed that rapamycin, a clinically approved drug, is an anti‐aging agent, which potentially could be employed to delay age‐related diseases, extending healthy life span. Most importantly, precisely because medicine is becoming so effective in saving lives, this increases a number of elderly patients with chronic and multiple diseases (Figure 1 from A to B), which necessitates multiple treatments all of which cost money. Saved by defibrillation from sudden death due to coronary atherosclerosis, a patient can live for many decades (with treatment) and may even die from another age-related disease. As “a side effect,” this increases a number of elderly people with chronic age-related diseases in constant need of health care (who would otherwise have died).
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
